A detailed history of Empirical Asset Management, LLC transactions in Liquidia Corp stock. As of the latest transaction made, Empirical Asset Management, LLC holds 10,704 shares of LQDA stock, worth $120,420. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,704
Previous 11,537 7.22%
Holding current value
$120,420
Previous $138,000 22.46%
% of portfolio
0.01%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$8.9 - $14.11 $7,413 - $11,753
-833 Reduced 7.22%
10,704 $107,000
Q2 2024

Aug 09, 2024

BUY
$11.96 - $15.71 $137,982 - $181,246
11,537 New
11,537 $138,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $724M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Empirical Asset Management, LLC Portfolio

Follow Empirical Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empirical Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Empirical Asset Management, LLC with notifications on news.